These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 10560332)
1. Evaluation of 18F-FDG positron emission tomography in gastric and oesophageal carcinoma. McAteer D; Wallis F; Couper G; Norton M; Welch A; Bruce D; Park K; Nicolson M; Gilbert FJ; Sharp P Br J Radiol; 1999 Jun; 72(858):525-9. PubMed ID: 10560332 [TBL] [Abstract][Full Text] [Related]
2. Computed tomography and positron emission tomography in the pre-operative staging of oesophageal carcinoma. Rankin SC; Taylor H; Cook GJ; Mason R Clin Radiol; 1998 Sep; 53(9):659-65. PubMed ID: 9766719 [TBL] [Abstract][Full Text] [Related]
3. Detection of response to chemotherapy using positron emission tomography in patients with oesophageal and gastric cancer. Couper GW; McAteer D; Wallis F; Norton M; Welch A; Nicolson M; Park KG Br J Surg; 1998 Oct; 85(10):1403-6. PubMed ID: 9782025 [TBL] [Abstract][Full Text] [Related]
4. Serial imaging using [18F]Fluorodeoxyglucose positron emission tomography and histopathologic assessment in predicting survival in a population of surgically resectable distal oesophageal and gastric adenocarcinoma following neoadjuvant therapy. Manoharan V; Lee S; Chong S; Yap J; Coupe N; Wilson R; Merrett N; Ng W; Lin M Ann Nucl Med; 2017 May; 31(4):315-323. PubMed ID: 28299585 [TBL] [Abstract][Full Text] [Related]
5. Impact of FDG-PET for staging of oesophageal cancer. Imdahl A; Hentschel M; Kleimaier M; Hopt UT; Brink I Langenbecks Arch Surg; 2004 Aug; 389(4):283-8. PubMed ID: 15197549 [TBL] [Abstract][Full Text] [Related]
6. The utility of FDG-PET for detecting multiple primary cancers in hypopharyngeal cancer patients. Kaida H; Ishibashi M; Kurata S; Uchiyama Y; Tanaka N; Abe T; Kobayashi M; Kaibara H; Uchida M; Nakashima T; Fujita H; Hayabuchi N Nuklearmedizin; 2009; 48(5):179-84. PubMed ID: 19639163 [TBL] [Abstract][Full Text] [Related]
7. The role of 18F-FDG PET/CT in the evaluation of oesophageal carcinoma. Chowdhury FU; Bradley KM; Gleeson FV Clin Radiol; 2008 Dec; 63(12):1297-309. PubMed ID: 18996259 [TBL] [Abstract][Full Text] [Related]
8. PET and PET-CT in esophageal and gastric cancer. Wieder HA; Krause BJ; Herrmann K Methods Mol Biol; 2011; 727():59-76. PubMed ID: 21331929 [TBL] [Abstract][Full Text] [Related]
9. Carbon-11 choline or FDG-PET for staging of oesophageal cancer? Jager PL; Que TH; Vaalburg W; Pruim J; Elsinga P; Plukker JT Eur J Nucl Med; 2001 Dec; 28(12):1845-9. PubMed ID: 11734925 [TBL] [Abstract][Full Text] [Related]
10. Laparoscopy, computerised tomography and fluorodeoxyglucose positron emission tomography in the management of gastric and gastro-oesophageal junction cancers. Mirza A; Galloway S Surg Endosc; 2016 Jul; 30(7):2690-6. PubMed ID: 26487234 [TBL] [Abstract][Full Text] [Related]
11. Clinical staging of patients with early esophageal adenocarcinoma: does FDG-PET/CT have a role? Cuellar SL; Carter BW; Macapinlac HA; Ajani JA; Komaki R; Welsh JW; Lee JH; Swisher SG; Correa AM; Erasmus JJ; Hofstetter WL J Thorac Oncol; 2014 Aug; 9(8):1202-6. PubMed ID: 25157774 [TBL] [Abstract][Full Text] [Related]
12. The role of PET scan in the preoperative management of oesophageal cancer. Liberale G; Van Laethem JL; Gay F; Goldman S; Nagy N; Coppens E; Gelin M; El Nakadi I Eur J Surg Oncol; 2004 Nov; 30(9):942-7. PubMed ID: 15498638 [TBL] [Abstract][Full Text] [Related]
13. The value of vesicant 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) in gastric malignancies. Tian J; Chen L; Wei B; Shao M; Ding Y; Yin D; Yao S Nucl Med Commun; 2004 Aug; 25(8):825-31. PubMed ID: 15266178 [TBL] [Abstract][Full Text] [Related]
14. Visualisation of metastatic oesophageal and gastric cancer and prediction of clinical response to palliative chemotherapy using 18FDG PET. Lorenzen S; Herrmann K; Weber WA; Wieder H; Hennig M; Ott K; Bredenkamp R; Peschel C; Schwaiger M; Lordick F Nuklearmedizin; 2007; 46(6):263-70. PubMed ID: 18084682 [TBL] [Abstract][Full Text] [Related]
15. Role of ¹⁸F 2-fluoro-2-deoxyglucose positron emission tomography in upper gastrointestinal malignancies. Smyth EC; Shah MA World J Gastroenterol; 2011 Dec; 17(46):5059-74. PubMed ID: 22171140 [TBL] [Abstract][Full Text] [Related]
16. Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle. Mertens LS; Fioole-Bruining A; Vegt E; Vogel WV; van Rhijn BW; Horenblas S BJU Int; 2013 Oct; 112(6):729-34. PubMed ID: 23790129 [TBL] [Abstract][Full Text] [Related]
17. FDG-PET in the initial staging of squamous cell oesophageal carcinoma. Buchmann I; Hansen T; Brochhausen C; Kneist W; Oberholzer K; Junginger T; Schreckenberger M; Bartenstein P Nuklearmedizin; 2006; 45(6):235-41. PubMed ID: 17149491 [TBL] [Abstract][Full Text] [Related]
18. [Fluorine-18 fluorodeoxyglucose-positron emission tomography imaging of carcinoma of cardia or fundus of stomach]. Wang T; Sun YE; Yu CH; Chang P; Yao SL; Tian JH; Wu X; Sun K; Yang B Zhonghua Wai Ke Za Zhi; 2006 May; 44(10):661-4. PubMed ID: 16784672 [TBL] [Abstract][Full Text] [Related]
19. Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography. Flanagan FL; Dehdashti F; Siegel BA; Trask DD; Sundaresan SR; Patterson GA; Cooper JD AJR Am J Roentgenol; 1997 Feb; 168(2):417-24. PubMed ID: 9016218 [TBL] [Abstract][Full Text] [Related]
20. Neoplasms of the esophagus and stomach. Dehdashti F; Siegel BA Semin Nucl Med; 2004 Jul; 34(3):198-208. PubMed ID: 15202101 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]